期刊
JOURNAL OF BIOMOLECULAR SCREENING
卷 13, 期 10, 页码 1025-1034出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1087057108326081
关键词
antimitotics; chromatin; haspin; kinase; time-resolved fluorescence resonance energy transfer
资金
- NIH/NCI [R01CA122608]
- Partners Center for Drug Discovery.
Haspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis. Its depletion by RNA interference results in failure of chromosome alignment and a block in mitosis. Haspin, therefore, is a novel target for development of antimitotic agents. We report the development of a high-throughput time-resolved fluorescence resonance energy transfer (TR-FRET) kinase assay for haspin. Histone H3 peptide was used as a substrate, and a europium-labeled H3T3ph phospho-specific monoclonal antibody was used to detect phosphorylation. A library of 137632 small molecules was screened at K m concentrations of ATP and peptide to allow identification of diverse inhibitor types. Reconfirmation of hits and IC50 determinations were carried out with the TR-FRET assay and by a radiometric assay using recombinant histone H3 as the substrate. A preliminary assessment of specificity was made by testing inhibition of 2 unrelated kinases. EC50 values in cells were determined using a cell-based ELISA of H3T3ph. Five compounds were selected as leads based on potency and chemical structure considerations. These leads form the basis for the development of specific inhibitors of haspin that will have clear utility in basic research and possible use as starting points for development of antimitotic anticancer therapeutics. ( Journal of Biomolecular Screening 2008: 1025-1034)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据